secwatch.observer — SEC 8-K summary
======================================

Issuer:     SS Innovations International, Inc. (SSII)
CIK:        0001676163
Form:       8-K
Filed at:   2026-03-10T23:59:59+00:00
Accession:  0001213900-26-025441
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SS Innovations Q4 revenue up 79% to $14.5M; raises $18.6M in private placement
------------------------------------------------------------------------------

- Q4 2025 revenue $14.5M (+79% YoY); gross margin 43.9%; net loss $2.5M ($0.01/share).
- Full year revenue $42.5M (+106% YoY); net loss $12.1M ($0.06/share) vs $19.2M loss in 2024.
- SSi Mantra installations: 40 in Q4 (+82% YoY), 103 in FY2025 (+119%); cumulative base 168 across 10 countries.
- Completed $18.6M private placement of 5.77M shares; insiders bought 1.3M shares at $4.00, non-affiliates at $3.00.
- FDA 510(k) review for SSi Mantra expected by mid-2026; CE marking pathway ongoing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676163/000121390026025441/0001213900-26-025441-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676163/000121390026025441/ea0280665-8k_ssinnovations.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-025441

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer